查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1529933

个人化细胞治疗市场：依细胞类型、依治疗领域、依最终使用者、按地区

Personalized Cell Therapy Market, By Cell Type, By Therapeutic Area, By End Users, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 157 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计2024年全球个人化细胞治疗市场规模为141.2亿美元，预计到2031年将达到650.1亿美元，2024年至2031年复合年增长率为24.4%。

报告范围 报告详情
基准年 2023年 2024年市场规模 141.2亿美元
实际资料 2019-2023 预测期 2024-2031
预测期，2024-2031年复合年增长率： 24.40% 2031 年金额预测 650.1亿美元
图：2024 年按地区分類的个人化细胞治疗市场占有率(%)
个人化细胞治疗市场-IMG1

推动全球个人化细胞治疗市场成长的是主要企业增加研发投资，以开发先进的细胞疗法来治疗各种慢性和危及生命的疾病。个人化细胞疗法从患者体内分离和操纵细胞以产生治疗效果。这个新领域有望开发癌症、神经系统疾病、心血管疾病等疾病的治疗方法。基因组学、细胞生物学和工程学的进步使科学家能够更好地了解细胞在健康和疾病中的功能。随着更多细胞治疗产品获得监管部门核准并应用于临床实践，该市场可能会成长。

市场动态：

全球个人化细胞治疗市场的成长是由癌症和其他疑难疾病盛行率上升、易患慢性病的老年人口增加、再生医学的广泛采用、细胞治疗的应用不断扩大以及生物技术的多种因素所推动的。 ，包括细胞研究的进展和细胞研究的重大投资。然而，治疗成本高、开发週期长以及临床试验的监管障碍可能会阻碍市场成长。 iPSC（诱导性多功能干细胞）技术的持续研究、CAR T细胞疗法的采用、同种异体细胞疗法的研发以及细胞疗法功效的证据的积累为利益相关人员提供了有利的机会。

本研究的主要特点

  • 本报告对全球个人化细胞治疗市场进行了详细分析，包括以2023年为基准年的预测期（2024-2031年）的市场规模（十亿美元）和年复合成长率（CAGR%） 。
  • 它还说明了各个细分市场的潜在商机，并为该市场提供了一系列有吸引力的投资提案。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
  • 它根据公司亮点、产品系列、主要亮点、财务表现和策略等参数，介绍了全球个人化细胞治疗市场的主要企业。
  • 据信，这份报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 全球个人化细胞治疗市场报告针对该行业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 透过用于分析全球个人化细胞治疗市场的各种策略矩阵，将有助于相关人员做出决策。

目录

第一章 研究目的与前提

  • 研究目的
  • 先决条件
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第三章 市场动态、法规与趋势分析

  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会
  • 影响分析
  • 市场趋势
  • 主要进展
  • 监管场景
  • 收购和合作场景
  • 资金筹措和投资
  • PEST分析
  • 波特的分析

第四章全球个人化细胞治疗市场－冠状病毒（COVID-19）大流行的影响

  • 整体影响
  • 政府倡议
  • COVID-19 对市场的影响

第五章全球个人化细胞治疗市场，依细胞类型，2019-2031（十亿美元）

  • 淋巴球
  • 间质干细胞
  • 造血干细胞
  • 其他的

第六章 全球个人化细胞治疗市场，依治疗领域，2019-2031（十亿美元）

  • 心血管疾病
  • 神经系统疾病
  • 发炎疾病
  • 糖尿病
  • 癌症

第七章 全球个人化细胞治疗市场，依最终使用者划分，2019-2031 年（十亿美元）

  • 医院
  • 居家护理
  • 专科诊所
  • 其他的

第八章全球个人化细胞治疗市场，按地区，2019-2031（十亿美元）

  • 拉丁美洲
  • 欧洲
  • 亚太地区
  • 中东

第9章 竞争格局

  • 公司简介
    • Thermo Fisher Scientific, Inc.
    • Novartis AG
    • Gilead Sciences, Inc.
    • Pfizer Inc.
    • Amgen Inc.
    • Bluebird Bio, Inc.
    • Personalis, Inc.
    • Adaptimmune Therapeutics PLC
    • BioNTech SE
    • Sangamo Therapeutics, Inc.
    • Regeneron Pharmaceuticals, Inc.
    • CRISPR Therapeutics AG
    • Caribou Biosciences, Inc.
    • Mustang Bio, Inc.
    • Fate Therapeutics, Inc.
    • Atara Biotherapeutics, Inc.
    • Holostem Terapie Avanzate Srl

第10章分析师建议

  • 命运之轮
  • 分析师观点
  • Coherent Opportunity Map

第十一章 参考文献与调查方法

  • 参考
  • 调查方法
简介目录
Product Code: CMI204

Global personalized cell therapy market is estimated to be valued at USD 14.12 Bn in 2024 and is expected to reach USD 65.01 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 24.4% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: US$ 14.12 Bn
Historical Data for: 2019 to 2023 Forecast Period: 2024 to 2031
Forecast Period 2024 to 2031 CAGR: 24.40% 2031 Value Projection: US$ 65.01 Bn
Figure. Personalized Cell Therapy Market Share (%), By Region 2024
Personalized Cell Therapy Market - IMG1

Global personalized cell therapy market growth is driven by increasing R&D investments by key players in developing advanced cell therapies for treating various chronic and life-threatening diseases. Personalized cell therapy involves isolation and manipulation of cells from patient's own body to produce therapeutic effects. This emerging field holds promise for developing curative treatments for cancer, neurological disorders, cardiovascular diseases and others. With advancements in genomics, cell biology and engineering technologies, scientists are gaining deeper understanding of how cells function in healthy and diseased conditions, thus, allowing them to exploit cells' therapeutic potential in a personalized way. The market can witness growth as more cell therapy products receive regulatory approvals and get adopted in clinical practice.

Market Dynamics:

Global personalized cell therapy market growth is driven by several factors such as rising prevalence of cancer and other incurable diseases, growing geriatric population susceptible to chronic illnesses, increasing adoption of regenerative medicines, expanding applications of cell therapies, advances in biotechnology, and heavy investments in cell-based research. However, high treatment costs, long development cycles, and regulatory hurdles surrounding clinical trials can hamper the market growth. Ongoing research on iPSC (induced pluripotent stem cells) technology, adoption of CAR T-cell therapies, development of allogenic cell therapies, growing body of evidence on effectiveness of cell therapies can offer lucrative opportunities for stakeholders.

Key Features of the Study:

  • This report provides in-depth analysis of the global personalized cell therapy market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global personalized cell therapy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Juno Therapeutics, Cellectis, Bellicum Pharmaceuticals, Vericel, Pharmicell, Pluristem Therapeutics, BioLineRx, Mesoblast.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • Global personalized cell therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global personalized cell therapy market.

Detailed Segmentation-

  • By Cell Type
    • Lymphocytes
    • Mesenchymal Stem Cell
    • Hematopoietic Stem Cell
    • Others
  • By Therapeutic Area
    • Cardiovascular Diseases
    • Neurological Disorders
    • Inflammatory Diseases
    • Diabetes
  • By End Users
    • Hospitals
    • Homecare
    • Specialty Clinics
    • Others
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Thermo Fisher Scientific, Inc.
    • Novartis AG
    • Gilead Sciences, Inc.
    • Pfizer Inc.
    • Amgen Inc.
    • Bluebird Bio, Inc.
    • Personalis, Inc.
    • Adaptimmune Therapeutics PLC
    • BioNTech SE
    • Sangamo Therapeutics, Inc.
    • Regeneron Pharmaceuticals, Inc.
    • CRISPR Therapeutics AG
    • Caribou Biosciences, Inc.
    • Mustang Bio, Inc.
    • Fate Therapeutics, Inc.
    • Atara Biotherapeutics, Inc.
    • Holostem Terapie Avanzate S.r.l

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Cell Type
    • Market Snapshot, By Therapeutic Area
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Personalized Cell Therapy Market - Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Personalized Cell Therapy Market, By Cell Type, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Lymphocytes
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Mesenchymal Stem Cell
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Hematopoietic Stem Cell
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Personalized Cell Therapy Market, By Therapeutic Area, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Cardiovascular Diseases
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Neurological Disorders
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Inflammatory Diseases
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Diabetes
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Cancer
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Personalized Cell Therapy Market, By End Users, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Hospitals
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Homecare
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Specialty Clinics
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Personalized Cell Therapy Market, By Region, 2019 - 2031, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Region, 2019-2031
    • Regional Trends
      • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
      • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Company Profiles
    • Thermo Fisher Scientific, Inc.
      • Company Highlights
      • Therapeutic Area Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Novartis AG
      • Company Highlights
      • Therapeutic Area Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Gilead Sciences, Inc.
      • Company Highlights
      • Therapeutic Area Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Pfizer Inc.
      • Company Highlights
      • Therapeutic Area Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Amgen Inc.
      • Company Highlights
      • Therapeutic Area Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Bluebird Bio, Inc.
      • Company Highlights
      • Therapeutic Area Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Personalis, Inc.
      • Company Highlights
      • Therapeutic Area Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Adaptimmune Therapeutics PLC
    • BioNTech SE
    • Sangamo Therapeutics, Inc.
    • Regeneron Pharmaceuticals, Inc.
    • CRISPR Therapeutics AG
    • Caribou Biosciences, Inc.
    • Mustang Bio, Inc.
    • Fate Therapeutics, Inc.
    • Atara Biotherapeutics, Inc.
    • Holostem Terapie Avanzate S.r.l

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact